References
- Gu, W.Z. and Brandwein, S.R. (1998) "Inhibition of type II collagen-induced arthritis in rats by triptolide", International Journal of Immunopharmacology, 20, 389–400.
- Cibere, J., Deng, Z., Lin, Y., Ou, R., He, Y., Wang, Z., et al. (2003) "A randomized double blind, placebo controlled trial of topical tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis", The Journal of Rheumatology, 30, 465 —467.
- Yang, S., Chen, J., Guo, Z., Xu, X.M., Wang, L., Pei, X.F., et al. (2003) "Triptolide inhibits the growth and metastasis of solid tumors", Molecular Cancer Therapeutics, 2, 65–72.
- Lee, KY., Park, JS., Jee, Y.K. and Rosen, G.D. (2002) "Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappakB activation", Experimental and Molecular Medicine, 34, 462–468.
- Tengchaisri, T., Chawengkirttikul, R., Rachaphaew, N., Reutrakul, V., Sangsuwan, R. and Sirisinha, S. (1998) "Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters", Cancer Letters, 133, 169–175.
- Chan, E.W., Cheng, S.C., Sin, F.W. and Xie, Y. (2001) "Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines", Toxicology Letters, 122, 81 — 87.
- Kiviharju, T.M., Lecane, P.S., Sellers, R.G. and Peehl, D.M. (2002) "Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells", Clinical Cancer Research, 8, 2666— 2674.
- Chapman, R.S., Whetton, A.D., Chresta, C.M. and Dive, C. (1995) "Characterization of drug resistance mediated via the suppression of apoptosis by Abelson protein tyrosine kinase", Molecular Pharmacology, 48, 334— 343.
- Amarante-Mendes, G.P., Naekyung, Kim. C., Liu, L., Huang, Y., Perkins, CL., et al. (1998) "Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3", Blood, 91, 1700–1705.
- Chang, W.T., Kang, J.J., Lee, KY., Wei, K., Anderson, E., Gotmare, S., et al. (2001) "Triptolide and Chemotherapy Cooperate in Tumor Cell Apoptosis A role for the p53 pathway", The Journal of Biological Chemistry, 276, 2221 —2227.
- Hamdane, M., David-Cordonnier, M.H. and D'Halluin, J.C. (1997) "Activation of p65 NF-kB protein by p210 BCR—ABL in a myeloid cell line (p210 BCR—ABL activates p65 NF-kB)", Oncogene, 15, 2267–2275.
- Skorski, T., Bellacosa, A., Nieborowska-Skorska, M., Majewski, M., Martinez, R., Choi, J.K., et al. (1997) "Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3K/Akt-dependent pathway", The EMBO Journal, 16, 6151— 6161.
- McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K., Green, D. and Cotter, T. (1994) "BCR-ABL maintains resistance of chronic myelogeneous leukemia cells to apoptotic death", Blood, 83, 1179 — 1187.
- Jiang, X.H., Wong, B.C., Lin, MC., Zhu, G.H., Kung, H.F., Jiang, S.H., et al. (2001) "Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells", Oncogene, 20, 8009–8018.
- Lee, KN., Chang, W., Qiu, D., Kao, P.N. and Rosen, G.D. (1999) "PG490 (Triptolide) cooperates with tumor necrosis factor-a to induce apoptosis in tumor cells", The Journal of Biological. Chemistry, 274, 13452–13455.
- Deininger, MW., Goldman, J.M., Lydon, N. and Melo, J.V. (1997) "The tyrosinekinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells", Blood, 90, 3691–3698.
- Fang, G., Kim, C.N., Perkins, CL., Ramadevi, N., Winton, E., Wittmann, S., et al. (2000) "CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs", Blood, 96, 2246— 2253.